200
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Associations of Obesity Indices with Bone Mineral Densities and Risk of Osteoporosis Stratified Across Diabetic Vascular Disease in T2DM Patients

, , , ORCID Icon, ORCID Icon & ORCID Icon
Pages 3459-3468 | Received 29 Jul 2022, Accepted 26 Oct 2022, Published online: 03 Nov 2022

References

  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. doi:10.1038/nrendo.2017.151
  • Kelley SS, Johnston RC. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646–650. doi:10.1016/0002-9343(93)90218-E
  • Osnes EK, Lofthus CM, Meyer HE, et al. Consequences of Hip fracture on activities of daily life and residential needs. Osteoporos Int. 2004;15:567–574. doi:10.1007/s00198-003-1583-0
  • Valderrábano RJ, Linares MI. Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol. 2018;4:9. doi:10.1186/s40842-018-0060-9
  • Zhao H, Zheng C, Gan K, Qi C, Ren L, Song G. High body mass index and triglycerides help protect against osteoporosis in patients with type 2 diabetes mellitus. J Diabetes Res. 2020;2020:1517879. doi:10.1155/2020/1517879
  • De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330–1338. doi:10.1007/s00198-005-1863-y
  • Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med. 2011;124:1043–1050. doi:10.1016/j.amjmed.2011.06.013
  • Zhao LJ, Jiang H, Papasian CJ, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2008;23:17–29. doi:10.1359/jbmr.070813
  • Schooling CM, Lam TH, Li ZB, et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med. 2006;166:1498–1504. doi:10.1001/archinte.166.14.1498
  • Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–563. doi:10.1093/ajcn/81.3.555
  • Kahn HS, Bullard KM, Barker LE, Imperatore G. Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS One. 2012;7:e50428. doi:10.1371/journal.pone.0050428
  • Caffarelli C, Alessi C, Nuti R, Gonnelli S. Divergent effects of obesity on fragility fractures. Clin Interv Aging. 2014;9:1629–1636. doi:10.2147/CIA.S64625
  • Leslie WD, Lix LM, Prior HJ, Derksen S, Metge C, O’Neil J. Biphasic fracture risk in diabetes: a population-based study. Bone. 2007;40:1595–1601. doi:10.1016/j.bone.2007.02.021
  • Fukunaga Y, Minamikawa J, Inoue D, Koshiyama H. Does insulin use increase bone mineral density in patients with non-insulin-dependent diabetes mellitus? Arch Intern Med. 1997;157:2668–2669. doi:10.1001/archinte.157.22.2668a
  • Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23:1–87. doi:10.4158/EP171764.APPGL
  • Thrailkill KM. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther. 2000;2:69–80. doi:10.1089/152091599316775
  • de L II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16:1713–1720. doi:10.1007/s00198-005-1909-1
  • Rizzoli R, Bischoff-Ferrari H, Dawson-Hughes B, Weaver C. Nutrition and bone health in women after the menopause. Women Health. 2014;10:599–608. doi:10.2217/whe.14.40
  • Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1980;51:1359–1364. doi:10.1210/jcem-51-6-1359
  • Dy CJ, Lamont LE, Ton QV, Lane JM. Sex and gender considerations in male patients with osteoporosis. Clin Orthop Relat Res. 2011;469:1906–1912. doi:10.1007/s11999-011-1849-3
  • Rinonapoli G, Ruggiero C, Meccariello L, Bisaccia M, Ceccarini P, Caraffa A. Osteoporosis in men: a review of an underestimated bone condition. Int J Mol Sci. 2021;23:22. doi:10.3390/ijms23010022
  • Binkley N. A perspective on male osteoporosis. Best Pract Res Clin Rheumatol. 2009;23:755–768. doi:10.1016/j.berh.2009.10.001
  • Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010;162:1009–1020. doi:10.1530/EJE-10-0015
  • Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30. doi:10.1186/1749-799X-6-30
  • Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005;289:E735–E745. doi:10.1152/ajpendo.00159.2005
  • Furst JR, Bandeira LC, Fan WW, et al. Advanced glycation endproducts and bone material strength in type 2 diabetes. J Clin Endocrinol Metab. 2016;101:2502–2510. doi:10.1210/jc.2016-1437
  • Chen Z, Lohman TG, Stini WA, Ritenbaugh C, Aickin M. Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res. 1997;12:144–151. doi:10.1359/jbmr.1997.12.1.144